Literature DB >> 7061848

Cell-mediated cytotoxicity against skin fibroblasts in atopic dermatitis.

D Y Leung, R Parkman, J Feller, N Wood, R S Geha.   

Abstract

Entities:  

Mesh:

Year:  1982        PMID: 7061848

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  9 in total

1.  Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon.

Authors:  D Y Leung; T Collins; L A Lapierre; R S Geha; J S Pober
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

Review 2.  Immunoregulatory abnormalities in atopic dermatitis.

Authors:  D Y Leung; R S Geha
Journal:  Clin Rev Allergy       Date:  1986-02

3.  Decreased natural killer cell activity in atopic eczema.

Authors:  T J Hall; R Rycroft; J Brostoff
Journal:  Immunology       Date:  1985-10       Impact factor: 7.397

4.  Interleukin 2 therapy in severe atopic dermatitis.

Authors:  K H Hsieh; C C Chou; S F Huang
Journal:  J Clin Immunol       Date:  1991-01       Impact factor: 8.317

5.  Natural killer cell activity in atopic dermatitis.

Authors:  M Viander; J Uksila; O Lassila; C T Jansén
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

Review 6.  The biology of the human natural killer cell.

Authors:  J C Roder; H F Pross
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

7.  The role of autoreactive T-cell hybridomas from autoimmune model mice.

Authors:  S Yanoma; I Aoki; N Ishii; K Tani; C S David; K Okuda
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

8.  Natural killer cell activity in asthma.

Authors:  T Timonen; B Stenius-Aarniala
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

9.  Thymopentin treatment in severe atopic dermatitis--clinical and immunological evaluations.

Authors:  K H Hsieh; M F Shaio; T N Liao
Journal:  Arch Dis Child       Date:  1992-09       Impact factor: 3.791

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.